Position in NVS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$493,354
+$16,622 QoQ
Shares Held
3,148
+0.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#893
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Investment Advisors, LLC holds $319,084,682 across 12 Drug Manufacturers - General names. NVS ranks #9 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
414,618 | $105,300,533 | |
| 2 | ABBV |
AbbVie Inc.
|
334,747 | $84,235,735 | |
| 3 | MRK |
Merck & Co., Inc.
|
376,564 | $48,388,474 | |
| 4 | LLY |
ELI LILLY & Co
|
29,637 | $35,547,509 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
93,913 | $11,864,968 | |
| 6 | AMGN |
Amgen Inc
|
31,607 | $11,445,526 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
194,661 | $11,216,366 | |
| 8 | PFE |
Pfizer Inc
|
398,271 | $9,590,365 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $493,354 | 3,148 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $476,732 | 3,121 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $441,046 | 3,199 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $453,841 | 3,539 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $471,212 | 3,894 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $447,480 | 4,014 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $408,993 | 4,203 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $485,959 | 4,225 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $493,761 | 4,638 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $436,832 | 4,516 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $453,153 | 4,488 | Shares | Sole | 2024-01-05 | |
| 2023-09-30 | $421,089 | 4,134 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $423,822 | 4,200 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $394,220 | 4,285 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $504,493 | 5,561 | Shares | Sole | 2023-01-05 | |
| 2022-09-30 | $427,100 | 5,619 | Shares | Sole | 2022-10-05 | |
| 2022-06-30 | $512,420 | 6,062 | Shares | Sole | 2022-07-06 | |
| 2022-03-31 | $507,897 | 5,788 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $504,789 | 5,771 | Shares | Sole | 2022-01-10 | |
| 2021-09-30 | $498,530 | 6,096 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $572,257 | 6,272 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $527,497 | 6,171 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $605,201 | 6,409 | Shares | Sole | 2021-01-21 | |
| 2020-09-30 | $556,196 | 6,396 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $558,626 | 6,396 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $526,360 | 6,384 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||